Guangdong Hybribio Biotech Co.,Ltd.

¥5.74As of Sun 8 Nov 2026, 12:00 UTC
SZSE:300639Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (1.53%)
Div yield —
ROE 2.02%
Diagnostics & Research
Beta (5Y) 0.51
PE TTM 53.92
TSR TTM (1.71%)
Mkt cap ¥3.603B
ROIC (1.08%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥6.30
9.84%
8.92%
Hold 2|0|4|11|1
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.08
0.08
0.09
0.09
28.88%
31.18%
30.66%
17.02%
Revenue¥M
412.0
406.2
409.9
428.2
12.38%
8.93%
6.52%
9.50%
Peers (US$540.0M)
Cap (US$)
PE
500.8M
—
Capital
TTM
5Y
10Y
Leveragex
2.764
0.462
0.354
EBIT/Intx
0.929
0.099
0.108
Own earn%
(169.82)
21.34
26.36
Sh yield%
56.33
43.13
41.15
Owners
Insiders/Inst%
3.50
60.26
Short interest%
4.26
SBC / revenue%
0.52
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
15
Op margin range%
14–24
$1 testx
0.0
Incr. ROIC%
4